228 related articles for article (PubMed ID: 27502103)
1. Bosentan as Adjunctive Therapy for Persistent Pulmonary Hypertension of the Newborn: Results of the Randomized Multicenter Placebo-Controlled Exploratory Trial.
Steinhorn RH; Fineman J; Kusic-Pajic A; Cornelisse P; Gehin M; Nowbakht P; Pierce CM; Beghetti M;
J Pediatr; 2016 Oct; 177():90-96.e3. PubMed ID: 27502103
[TBL] [Abstract][Full Text] [Related]
2. Endothelin receptor antagonists for persistent pulmonary hypertension in term and late preterm infants.
More K; Athalye-Jape GK; Rao SC; Patole SK
Cochrane Database Syst Rev; 2016 Aug; 2016(8):CD010531. PubMed ID: 27535894
[TBL] [Abstract][Full Text] [Related]
3. Effect of bosentan therapy in persistent pulmonary hypertension of the newborn.
Maneenil G; Thatrimontrichai A; Janjindamai W; Dissaneevate S
Pediatr Neonatol; 2018 Feb; 59(1):58-64. PubMed ID: 28735030
[TBL] [Abstract][Full Text] [Related]
4. Effect of early adjunctive use of oral sildenafil and inhaled nitric oxide on the outcome of pulmonary hypertension in newborn infants. A feasibility study.
Al Omar S; Salama H; Al Hail M; Al Rifai H; Bunahia M; El Kasem W; Siddiqui FJ; Dilawar M; Yassin H; Masud F; Mohamed A; Mansour A
J Neonatal Perinatal Med; 2016 Sep; 9(3):251-9. PubMed ID: 27589542
[TBL] [Abstract][Full Text] [Related]
5. Four patterns of response to inhaled nitric oxide for persistent pulmonary hypertension of the newborn.
Goldman AP; Tasker RC; Haworth SG; Sigston PE; Macrae DJ
Pediatrics; 1996 Oct; 98(4 Pt 1):706-13. PubMed ID: 8885950
[TBL] [Abstract][Full Text] [Related]
6. Oral sildenafil in infants with persistent pulmonary hypertension of the newborn: a pilot randomized blinded study.
Baquero H; Soliz A; Neira F; Venegas ME; Sola A
Pediatrics; 2006 Apr; 117(4):1077-83. PubMed ID: 16585301
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and Safety of IV Sildenafil in the Treatment of Newborn Infants with, or at Risk of, Persistent Pulmonary Hypertension of the Newborn (PPHN): A Multicenter, Randomized, Placebo-Controlled Trial.
Pierce CM; Zhang MH; Jonsson B; Iorga D; Cheruvu N; Balagtas CC; Steinhorn RH
J Pediatr; 2021 Oct; 237():154-161.e3. PubMed ID: 34052232
[TBL] [Abstract][Full Text] [Related]
8. A randomized, double-blind, placebo-controlled, prospective study of bosentan for the treatment of persistent pulmonary hypertension of the newborn.
Mohamed WA; Ismail M
J Perinatol; 2012 Aug; 32(8):608-13. PubMed ID: 22076415
[TBL] [Abstract][Full Text] [Related]
9. Low-dose nitric oxide therapy for persistent pulmonary hypertension of the newborn. Clinical Inhaled Nitric Oxide Research Group.
Clark RH; Kueser TJ; Walker MW; Southgate WM; Huckaby JL; Perez JA; Roy BJ; Keszler M; Kinsella JP
N Engl J Med; 2000 Feb; 342(7):469-74. PubMed ID: 10675427
[TBL] [Abstract][Full Text] [Related]
10. Inhaled nitric oxide for the early treatment of persistent pulmonary hypertension of the term newborn: a randomized, double-masked, placebo-controlled, dose-response, multicenter study. The I-NO/PPHN Study Group.
Davidson D; Barefield ES; Kattwinkel J; Dudell G; Damask M; Straube R; Rhines J; Chang CT
Pediatrics; 1998 Mar; 101(3 Pt 1):325-34. PubMed ID: 9480993
[TBL] [Abstract][Full Text] [Related]
11. Inhaled nitric oxide and gentle ventilation in the treatment of pulmonary hypertension of the newborn--a single-center, 5-year experience.
Gupta A; Rastogi S; Sahni R; Bhutada A; Bateman D; Rastogi D; Smerling A; Wung JT
J Perinatol; 2002 Sep; 22(6):435-41. PubMed ID: 12168118
[TBL] [Abstract][Full Text] [Related]
12. Effects of the dual endothelin-receptor antagonist bosentan in patients with pulmonary hypertension: a randomised placebo-controlled study.
Channick RN; Simonneau G; Sitbon O; Robbins IM; Frost A; Tapson VF; Badesch DB; Roux S; Rainisio M; Bodin F; Rubin LJ
Lancet; 2001 Oct; 358(9288):1119-23. PubMed ID: 11597664
[TBL] [Abstract][Full Text] [Related]
13. [Persistent pulmonary hypertension in premature and newborn infants: selective pulmonary vasodilation with inhaled nitric oxide (iNO)].
Herkenhoff M; Schaible T; Reiss I; Kandzora J; Möller J; Gortner L
Z Geburtshilfe Neonatol; 1998; 202(1):25-9. PubMed ID: 9577919
[TBL] [Abstract][Full Text] [Related]
14. Airway function in infants treated with inhaled nitric oxide for persistent pulmonary hypertension.
Hoskote AU; Castle RA; Hoo AF; Lum S; Ranganathan SC; Mok QQ; Stocks J
Pediatr Pulmonol; 2008 Mar; 43(3):224-35. PubMed ID: 18203182
[TBL] [Abstract][Full Text] [Related]
15. [Clinical effect of combination therapy with high-frequency oscillation ventilation, pulmonary surfactant and inhaled nitric oxide in the treatment of neonatal hypoxemic respiratory failure].
Lin XZ; Zheng Z; Li YD; Lai JD; Yao LS; Lan ZY; Huang J; Lin YY; Chen PH; Chen HQ
Zhongguo Dang Dai Er Ke Za Zhi; 2013 Dec; 15(12):1068-73. PubMed ID: 24342198
[TBL] [Abstract][Full Text] [Related]
16. Randomized controlled trial of early compared with delayed use of inhaled nitric oxide in newborns with a moderate respiratory failure and pulmonary hypertension.
González A; Fabres J; D'Apremont I; Urcelay G; Avaca M; Gandolfi C; Kattan J
J Perinatol; 2010 Jun; 30(6):420-4. PubMed ID: 19890345
[TBL] [Abstract][Full Text] [Related]
17. Bosentan improves exercise capacity in adolescents and adults after Fontan operation: the TEMPO (Treatment With Endothelin Receptor Antagonist in Fontan Patients, a Randomized, Placebo-Controlled, Double-Blind Study Measuring Peak Oxygen Consumption) study.
Hebert A; Mikkelsen UR; Thilen U; Idorn L; Jensen AS; Nagy E; Hanseus K; Sørensen KE; Søndergaard L
Circulation; 2014 Dec; 130(23):2021-30. PubMed ID: 25446057
[TBL] [Abstract][Full Text] [Related]
18. Inhaled nitric oxide for neonates with persistent pulmonary hypertension of the newborn in the CINRGI study: time to treatment response.
Nelin LD; Potenziano JL
BMC Pediatr; 2019 Jan; 19(1):17. PubMed ID: 30636626
[TBL] [Abstract][Full Text] [Related]
19. Acute response to inhaled nitric oxide in newborns with respiratory failure and pulmonary hypertension.
Day RW; Lynch JM; White KS; Ward RM
Pediatrics; 1996 Oct; 98(4 Pt 1):698-705. PubMed ID: 8885949
[TBL] [Abstract][Full Text] [Related]
20. Factors affecting the response to inhaled nitric oxide therapy in persistent pulmonary hypertension of the newborn infants.
Hwang SJ; Lee KH; Hwang JH; Choi CW; Shim JW; Chang YS; Park WS
Yonsei Med J; 2004 Feb; 45(1):49-55. PubMed ID: 15004868
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
